Daniel J. Klionsky, Eric H. Baehrecke, John H. Brumell, Charleen T. Chu, Patrice Codogno, Ana Marie Cuervo, Jayanta Debnath, Vojo Deretic, Zvulun Elazar, Eeva-Liisa Eskelinen, Steven Finkbeiner, Juan Fueyo-Margareto, David A. Gewirtz, Marja Jäättelä, Guido Kroemer, Beth Levine, Thomas J. Melia, Noboru Mizushima, David C. Rubinsztein, Anne Simonsen, Andrew Thorburn, Michael Thumm and Sharon A. Tooze

Daniel J. Klionsky

Corresponding author: klionsky@umich.edu
Life Sciences Institute, and Departments of Molecular, Cellular and Developmental Biology, and Biological Chemistry; University of Michigan; Ann Arbor, MI USA

Eric H. Baehrecke

Department of Cancer Biology; University of Massachusetts Medical School; Worcester, MA USA

John H. Brumell

Program in Cell Biology; The Hospital for Sick Children; Toronto, ON Canada

Charleen T. Chu

Department of Pathology; University of Pittsburgh School of Medicine; Pittsburgh, PA USA

Patrice Codogno

INSERM U984, and the Université Paris-Sud 11; Châtenay-Malabry, France

Ana Marie Cuervo

Department of Developmental and Molecular Biology; Marion Bessin Liver Research Center; Institute for Aging Research; Albert Einstein College of Medicine; Bronx, NY USA

Jayanta Debnath

Department of Pathology; University of California, San Francisco; San Francisco, CA USA

Vojo Deretic

Department of Molecular Genetics and Microbiology; University of New Mexico Health Sciences Center; Albuquerque, NM USA

Zvulun Elazar

Department of Biological Chemistry; The Weizmann Institute of Science; Rehovot, Israel

Eeva-Liisa Eskelinen

Department of Biosciences; University of Helsinki; Helsinki, Finland

Steven Finkbeiner

Gladstone Institute of Neurological Disease, and Departments of Neurology and Physiology; University of California, San Francisco; San Francisco, CA USA

Juan Fueyo-Margareto

Department of Neuro-Oncology; MD Anderson Cancer Center; University of Texas; Houston, TX USA

David A. Gewirtz

Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA

Marja Jäättelä

Department of Apoptosis; Danish Cancer Society; Copenhagen, Denmark

Guido Kroemer

Centre de Recherche des Cordeliers; INSERM U872; Faculty of Medicine of the University of Paris Descartes; Paris, France

Beth Levine

Howard Hughes Medical Institute and Department of Internal Medicine; University of Texas Southwestern Medical Center; Dallas, TX USA

Thomas J. Melia

Department of Cell Biology; Yale University; New Haven, CT USA

Noboru Mizushima

Department of Physiology and Cell Biology; Tokyo Medical and Dental University; Tokyo, Japan

David C. Rubinsztein

Department of Medical Genetics; Cambridge Institute for Medical Research; Cambridge, UK

Anne Simonsen

Department of Biochemistry; Institute of Basic Medical Sciences; University of Oslo; Oslo, Norway

Andrew Thorburn

Department of Pharmacology; University of Colorado Cancer Center; Denver, CO USA

Michael Thumm

Zentrum Biochemie und Molekulare Zellbiologie; Georg-August-Universitaet; Goettingen, Germany

Sharon A. Tooze

London Research Institute; Cancer Research UK; London, UK

The study of autophagy is rapidly expanding, and our knowledge of the molecular mechanism and its connections to a wide range of physiological processes has increased substantially in the past decade. The vocabulary associated with autophagy has grown concomitantly. In fact, it is difficult for readers-even those who work in the field-to keep up with the ever-expanding terminology associated with the various autophagy-related processes. Accordingly, we have developed a comprehensive glossary of autophagy-related terms that is meant to provide a quick reference for researchers who need a brief reminder of the regulatory effects of transcription factors and chemical agents that induce or inhibit autophagy, the function of the autophagy-related proteins, and the roles of accessory components and structures that are associated with autophagy.